Acer Therapeutics Inc.
ACERDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069308
Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Acer Therapeutics Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q4 2021
- Shares held
- 1.42M
- −49.8K (−3.4%) vs. Q4 2021
- Total value
- $4.12M
- +$768.1K (+22.9%) vs. Q4 2021
- New holders
- 2
- 5 more added
- Sold out
- 5
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 30 | $3.40M |
| Q2 2023 | 27 | $2.32M |
| Q1 2023 | 26 | $3.48M |
| Q4 2022 | 32 | $6.14M |
| Q3 2022 | 28 | $2.22M |
| Q2 2022 | 28 | $1.96M |
| Q1 2022 | 21 | $4.12M |
| Q4 2021 | 24 | $3.35M |
| Q3 2021 | 25 | $3.91M |
| Q2 2021 | 30 | $4.47M |
| Q1 2021 | 30 | $5.15M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Acer Therapeutics Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 777,820 | $2.26M | 0.16% | −123,470−13.7% | Reduced |
| Vanguard Group Inc | 278,215 | $807.0K | 0.00% | +99,335+55.5% | Added |
| BlackRock Inc. | 103,040 | $300.0K | 0.00% | −1,269−1.2% | Reduced |
| Goldman Sachs Group Inc | 95,233 | $276.0K | 0.00% | −110−0.1% | Reduced |
| Geode Capital Management, LLC | 84,171 | $244.0K | 0.00% | −590−0.7% | Reduced |
| State Street Corp | 25,565 | $74.0K | 0.00% | +600+2.4% | Added |
| Renaissance Technologies LLC | 22,000 | $64.0K | 0.00% | +4,600+26.4% | Added |
| Northern Trust Corp | 19,138 | $55.0K | 0.00% | −344−1.8% | Reduced |
| Bank of New York Mellon Corp | 11,133 | $32.0K | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 922 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 798 | $2.00K | 0.00% | −435−35.3% | Reduced |
| FMR LLC | 590 | $2.00K | 0.00% | +590 | New |
| Burleson & Company, LLC | 365 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 179 | $519 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 58 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8 | $0 | 0.00% | +7+700.0% | Added |
| JFS Wealth Advisors, LLC | 24 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 33 | $0 | 0.00% | +7+26.9% | Added |
| Simplex Trading, LLC | 242 | $0 | 0.00% | +242 | New |
| Raymond James & Associates | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,576−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Edge Wealth Management LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |